Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
Titel:
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
Auteur:
Atanasio, A. Vanni, A. Maggi, L. Pilerci, S. Mazzoni, A. Capone, M. Crupi, F. Cicogna, P. Boldrini, V. Tekle, S. Colao, M.G. Borella, M. Paoli, C. Rossolini, G.M. Vannucchi, A.M. Annunziato, F. Guglielmelli, P.